NEW YORK (GenomeWeb) – Diagnostics company Applied Proteomics plans to release a second-generation version of its SimpliPro Colon proteomic colon cancer test within the next several months.

Like the original test, the new version is intended for increasing patient compliance with recommended colonoscopies in patients with elevated risk of colon cancer.

It improves upon the first-generation test primarily by offering higher specificity. Additionally, the new test will run on a multiplex platform from Meso Scale Discovery, which will lower costs, said API CEO Premal Shah.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.